Pathological complete responses were noted in 37 ( 536 % , 95 % CI 412-657 ) of the PET responders , 21 ( 438 % , 295-588 ) of those in group A , and six ( 240 % , 94-451 ) of those in group B. Incidences of grade 3-4 adverse events were similar in all three groups .